Medreich PLC
Registered name: MEDREICH PLC
Medreich PLC made £32.7m revenue and £440k profit in the year to 31 Mar 2026. read from filing text
Medreich PLC’s revenue fell 15% to £32.7m in the year to 31 Mar 2026, with £440k profit and 32 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Feltham; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Feltham, London
- Age
- 30 yrs · since 1995
- Type
- Public Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The parent company is Medreich Ltd, a company incorporated in India.”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 | 31 Mar 2026 |
|---|---|---|---|---|
| Disclosure | Profit only | Profit only | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | — | — | £38.5m | £32.7m |
| Cost of sales | £39.3m | £38.7m | £37.3m | £24m |
| Gross profit | — | — | £9.2m | £8.6m |
| Operating profit | — | — | £2.4m | £650k |
| Profit before tax | £2.4m | £5.2m | £3.6m | £608k |
| Profit after tax | £1.9m | £4m | £2.6m | £440k |
| Profit (best available) | £1.9m | £4m | £2.6m | £440k |
| Staff costs | £2.2m | £2.2m | £2.3m | £1.7m |
| Employees (average) | 29 | 33 | 33 | 32 |
| Ratios | ||||
| Profit margin | — | — | 6.7% | 1.4% |
| Gross margin | — | — | 24% | 26.4% |
| Revenue per employee | — | — | £1.2m | £1m |
| Profit per employee | £66.7k | £121k | £77.9k | £13.7k |
| Cash conversion | — | — | −275.3% | −50.1% |
| Growth (year on year) | ||||
| Revenue growth | — | — | — | ▼15.1% |
| Profit growth | — | ▲106.9% | ▼35.7% | ▼82.9% |
| Headcount growth | — | ▲13.8% | 0% | ▼3% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £2.2m | £1.6m | £4m | £1.1m |
| Net assets | £28.1m | £32.1m | £34.7m | £26.2m |
| Fixed assets | £16.8m | £17.6m | £18.4m | £12.7m |
| Current assets | £30.6m | £33m | £35.8m | £22.5m |
| Debtors | £12.6m | £12.8m | £10.5m | £7.1m |
| Deferred income | £1.5m | £3.1m | £2.7m | £1.9m |
| Cash from operations | −£5.1m | −£4.5m | −£6.6m | −£326k |
| Source | FullAccounts · bulk data May 2024 | FullAccounts · bulk data May 2024 | FullAccounts · bulk data May 2025 | FullAccounts · bulk data May 2026 |
How the business works
- Profit margin
- 1.4%
- Profit ÷ revenue.
- Gross margin
- 26.4%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1m
- Revenue ÷ average employees.
- Profit per employee
- £13.7k
- Profit ÷ average employees.
- Cash conversion
- −50.1%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 38.9%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 5.7%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 21.7%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼25%
- Now £26.2m
- Cash at bank
- ▼72%
- Now £1.1m
- Headcount
- ▼3%
- Now 32
- Deferred income
- ▼31%
- Now £1.9m
- Fixed assets
- ▼31%
- Now £12.7m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Paul Murray PLCSouthampton · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £1.7m
- Staff
- 92
- Ims Euro LimitedStockport · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £5.5m
- Staff
- 83
- Bowmed Ibisqus LimitedManchester · Wholesale of pharmaceutical goods
- Revenue
- £32m
- Profit
- £3.4m
- Staff
- 11
- Beta Pharmaceuticals LimitedWitham · Wholesale of pharmaceutical goods
- Revenue
- £34.3m
- Profit
- £120k
- Staff
- 61
- Attends LimitedWakefield · Wholesale of pharmaceutical goods
- Revenue
- £35.9m
- Profit
- £635k
- Staff
- 23
- New England Biolabs (U.K.) LimitedHitchin · Wholesale of pharmaceutical goods
- Revenue
- £36m
- Profit
- £1.8m
- Staff
- 44
Sources
Latest figures from FullAccounts for the year to 31 Mar 2026 (profit £440k), from the Companies House accounts bulk data published May 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.